Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
IS08 - Symposium by Pfizer: EGFR+ and ALK+ NSCLC: More Options, Right Choices (Not IASLC CME Accredited)
- 07:00 - 08:00
- 9/08/2019
- Location: Vienna (2016)
- Type: Industry Symposia & Workshops
- Track:
-
+
ES10 - Oncology Drug Approval: Challenges and Opportunities
- 13:30 - 15:00
- 9/08/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Educational Session
- Track: Advanced NSCLC
- Moderators:Caicun Zhou, Alice T. Shaw
-
+
ES10.01 - US Food and Drug Administration
13:30 - 13:45 | Presenter: Gideon M Blumenthal
- Abstract
Loading... -
+
ES10.02 - Japan Pharmaceuticals and Medical Devices Agency
13:45 - 14:00 | Presenter: Sumimasa Nagai
- Abstract
Loading... -
+
ES10.03 - China National Medical Products Administration (Formerly CFDA)
14:00 - 14:15 | Presenter: Tony Mok
- Abstract
No abstract available for this presentation
-
+
ES10.04 - European Medicines Agency
14:15 - 14:30 | Presenter: Jorge Camarero
- Abstract
Loading... -
+
ES10.05 - Brazilian Health Regulatory Agency - Agência Nacional de Vigilância Sanitária
14:30 - 14:45 | Presenter: Carlos Gil Ferreira
- Abstract
Loading... -
+
ES10.06 - Q&A
14:45 - 15:00
- Abstract
No abstract available for this presentation
-
+
ES14 - What First Line in Oncogene Addicted NSCLC
- 15:15 - 16:45
- 9/08/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Educational Session
- Track: Targeted Therapy
- Moderators:Dolores Isla, Jessica Menis
-
+
ES14.02 - First Line in ALK Translocated Patients
15:30 - 15:45 | Presenter: Alice T. Shaw
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-84 - Interaction of Lorlatinib with CYP2B6, CYP2C9, UGT, and P-gp Probe Drugs in Patients with Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Joseph Chen | Author(s): Alessandra Bearz, Dong-Wan Kim, Hirva Mamdani, Jessica R Bauman, Rita Chiari, Sai-Hong Ignatius Ou, Benjamin J Solomon, Ross Soo, Enriqueta Felip, Alice T. Shaw, Jill S. Clancy, Kimberly Lee, Melissa O'Gorman, Cherie Tanski, Yazdi K. Pithavala
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.11 - STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
15:10 - 15:15 | Presenter: John Victor Heymach | Author(s): Ferdinandos Skoulidis, Kathryn C. Arbour, Matthew Hellmann, Pradnya Dinkar Patil, Melina E Marmarelis, Dwight Hall Owen, Mark Awad, Joseph C. Murray, Benjamin Philip Levy, Jessica Hellyer, Justin F. Gainor, Tyler Stewart, Sarah B. Goldberg, Anastasios Dimou, Christine M Bestvina, Amy Lauren Cummings, Yasir Elamin, Vincent Lam, Jianjun Zhang, Catherine Shu, Jonathan Wesley Riess, Collin M Blakely, Chad V. Pecot, Laura Mezquita, Fabrizio Tabbò, Adrian G Sacher, Matthias Scheffler, Biagio Ricciuti, Deepti Venkatraman, Hira Rizvi, Corinne Liu, Rocio Perez Johnston, Ying Ni, Joseph Azok, Melanie Wain Kier, Sharyn I Katz, Kurtis D. Davies, Jeremy P Segal, Lauren Ritterhouse, Hiram Shaish, LUDOVIC Lacroix, Regan Memmott, John R Madrigal, Jonathan Goldman, Sally CM Lau, Jonathan Killam, Zenta Walther, Brett Carter, Mark Woodcock, Jack Roth, Stephen Swisher, Natasha B Leighl, Subba Digumarthy, Meghan Mooradian, Julia Rotow, Juergen Wolf, Giorgio Vittorio Scagliotti, David Planchard, Benjamin Besse, Trever G Bivona, David R Gandara, Edward Garon, Naiyer A Rizvi, D. Ross Camidge, Kurt A Schalper, Roy S. Herbst, Alice T. Shaw, Joel W Neal, Heather A Wakelee, Julie R Brahmer, Pasi A Jänne, David P Carbone, Charu Aggarwal, Nathan Pennell, Charles M Rudin, Vassiliki A Papadimitrakopoulou
- Abstract
Loading...
-
+
MA14 - The Adequate MTarget Is Still the Issue
- 15:45 - 17:15
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Diego Signorelli, Juergen Wolf
-
+
MA14.02 - Entrectinib in Patients with ROS1-Positive NSCLC or NTRK Fusion-Positive Solid Tumors with CNS Metastases
15:50 - 15:55 | Presenter: Luis Paz-Ares | Author(s): Rafal Dziadziuszko, Alexander Drilon, Tom John, Matthew G Krebs, George Demetri, Alice T. Shaw, Salvatore Siena, Juergen Wolf, Anna F Farago, Brian Simmons, Chenglin Ye, Xinhui Huang, Robert C. Doebele
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-04 - NCI-NRG Oncology ALK PROTOCOL (NRG-LU003): A Biomarker-Driven Protocol for Previously Treated ALK-Positive Non-Squamous NSCLC Patients
10:15 - 10:15 | Presenter: Shakun Malik | Author(s): Chen Hu, Alice T. Shaw, Edward Korn, Anne Tsao, Robert C. Doebele, Thomas Stinchcombe, Christine M Lovly, Jeffery D. Bradley
- Abstract
Loading...
-
+
OA15 - Targeted Agents and Immunotherapy for Small Cell Lung Cancer
- 14:30 - 16:00
- 9/10/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Raffaele Califano, Charles M Rudin
-
+
OA15.01 - Combination Olaparib and Temozolomide in Relapsed Small Cell Lung Cancer: Updated Results from Phase 1/2 Clinical Trial
14:30 - 14:40 | Presenter: Anna F Farago | Author(s): Beow Yeap, Rebecca S Heist, J Paul Marcoux, Deepa Rangachari, David Barbie, Elizabeth Kennedy, Mari Mino-Kenudson, Alice T. Shaw
- Abstract
Loading...